| Name | Title | Contact Details |
|---|
Iowa Health Syst Poison Cntrl is a Sioux City, IA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Hospice of the Chesapeake`s mission is to care for life throughout the journey with illness and loss. Hospice of the Chesapeake provides physical, psycho-social and spiritual support services to individuals living with and affected by advanced illness. These services are provided wherever the patient calls home. Hospice of the Chesapeake is committed to providing the best possible care for all regardless of their inability to pay. Using a team-oriented approach involving our physicians, nurses, social workers, home health aides, chaplains and counselors, allows us to ensure quality and compassionate care. Additionally, grief support services are available to all members of the community who have lost a loved one including community members who have experienced traumatic or sudden loss. When care at home is not possible, we can provide services at our inpatient care center. The Chesapeake Life Center at Hospice of the Chesapeake provides individual grief counseling and support groups for a variety of populations including adults who have lost a loved one, children and teens, and survivors of homicide and suicide. Through Chesapeake Life Center, we operate two weekend camps for grieving children and teens. We are unique in that we provide grief support services to anyone in the community seeking support including those who have experienced a traumatic or sudden loss. The scope of services far exceeds that which is provided for in the Medicare Hospice Benefit.
Blueprint Medicines is developing a new generation of highly selective and potent kinase therapies to dramatically improve the lives of patients with genomically defined diseases. Our approach is rooted in a deep understanding of the genetic blueprint of cancer and other diseases driven by the abnormal activation of kinases. Our ability to identify novel drivers of disease, coupled with our proprietary library of novel and diverse chemical compounds, uniquely enables us to craft kinase therapies against new and difficult-to-drug targets. We are boldly advancing a deep pipeline of highly targeted therapies against previously unaddressed drivers of disease. By focusing on genomically defined subsets of patients, we believe we can identify the people most likely to respond to our therapies, resulting in a more efficient clinical development path with a greater likelihood of success and better outcomes for patients. We see a substantial opportunity in kinase drug discovery and development to deliver breakthrough medicines that allow patients to live longer with better quality of life and prevent recurrences of disease. Kinases are involved in many hallmarks of tumor biology and are proven cancer drug targets. Currently approved drugs focus on less than 5 percent of known kinases, and the function of most kinases is unknown. Led by a team of industry innovators with a track record of bringing life-changing drugs to market, we believe Blueprint Medicines has the experience and expertise to deliver on the tremendous untapped potential of kinase therapies to improve patients’ lives. We don’t think in small steps. We think in giant leaps. We are driven by the pursuit of new ideas, new innovations, and new ways of thinking.
Medwatch is a Lake Mary, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Healthcall is a Southfield, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.